Epidarex portfolio company Harpoon acquired by Edwards Lifesciences
Epidarex Capital (Epidarex) portfolio company Harpoon Medical (Harpoon), a pioneer in beating-heart repair for degenerative mitral regurgitation (DMR), has been acquired by Edwards Lifesciences for up to USD250 million. Under the terms of the merger agreement, Edwards paid USD100 million in cash for Harpoon at closing on 1 December, 2017